ESR1 and neoplasm: In a preclinical study by Paquette et al. involving ER-positive and ER-knockdown tumors, [18F]4FMFES was able to differentiate between positive and negative ER tumors and demonstrated significantly higher tumor uptake and TBR compared to [18F]FES.